Showing results (271-280 of 319) with videos related to
Sort By:
Pageof 32
Neurochemistry International|March 7, 2003
Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson's diseaseG E Gibson, A E Kingsbury, H Xu, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 19, 2004
Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsyD C Paviour, J M Schott, J M Stevens, et al.Archives of Neurology|October 1, 1989
Anal sphincter dysfunction in Parkinson's diseaseS E Mathers, P A Kempster, P J Law, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 2004
DJ-1 mutations in Parkinson's diseaseD G Healy, P M Abou-Sleiman, E M Valente, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2004
Tau gene and Parkinson's disease: a case-control study and meta-analysisD G Healy, P M Abou-Sleiman, A J Lees, et al.Brain : a Journal of Neurology|April 4, 2008
Clinical outcomes of progressive supranuclear palsy and multiple system atrophyS S O'Sullivan, L A Massey, D R Williams, et al.Psychopharmacology|April 14, 1978
Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'J D Elsworth, V Glover, G P Reynolds, et al.Annals of Neurology|October 1, 1992
Alpha-tocopherol levels in brain are not altered in Parkinson's diseaseD T Dexter, R J Ward, F R Wells, et al.Brain : a Journal of Neurology|April 5, 2001
Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystoniaA Münchau, J D Palmer, D Dressler, et al.Journal of Neurochemistry|July 1, 1990
Decreased ferritin levels in brain in Parkinson's diseaseD T Dexter, A Carayon, M Vidailhet, et al.Pageof 32